Board of Directors

Dr Erich Platzer

Dr Erich Platzer / Chairman

Dr Erich Platzer, MD, is an Investment Advisor at HBM BioVentures AG. Previously, he has been Head of Oncology at Roche, Switzerland. Dr Platzer has over 10 years of operating experience in product development and marketing and has been responsible for various strategic corporate partnerships. ... more

Dr Dinnies von der Osten / Vice Chairman

Dr Dinnies von der Osten / Vice Chairman

Dr Dinnies von der Osten has spent appr. 20 years in the venture and private capital  sector, where he served in several positions. His experience encompasses financing companies in the space of life sciences including biotechnology, nanotechnology, advanced materials, mechanical engineering and clean tech technologies. Dr von der Osten holds a PhD degree in economics from Freie Universität Berlin.

Prof Dr Georg Frank

Prof Dr Georg Frank

Prof Dr Georg Frank is currently engaged in several positions including as a consultant in the biotech industry. He has been the Managing Director of Bayer Bitterfeld GmbH. Prior to this he had several Executive Management positions at Bayer AG in Germany and in the US including Director R & D and Director Strategic Development of the Self Medication Division. He received a Masters Degree in Biology and a PhD in Chemistry and is a Honorary Professor in Chemistry at the University of … more

Dr Olivier Litzka

Dr Olivier Litzka, Edmond de Rothschild Investment Partners

Dr Jörg Neermann

Jörg Neermann, PhD, joined LSP as a Partner in the Munich Office in early 2007 and serves as member of the supervisory board of Affimed Therapeutics (D), Vivendy (CH) and Curetis (D) and Probiodrug (D). ... more

Dr Axel Polack

Dr Axel Polack

Dr Axel Polack joined TVM Capital in 2000, and is a General Partner for life sciences in the firm's Munich office. He is a member of the Board of Directors of Noxxon Pharma AG (Berlin, Germany) and Genetix Pharmaceuticals, Inc. (Cambridge, MA), and Invendo Medical (Kissing, Germany). He also represents the interests of TVM Capital with f-star and Probiodrug AG. … more